Maine’s Opioid Crisis: A Rising Death Toll!

Slides:



Advertisements
Similar presentations
The Patient Safety Challenge in the UK Dr Kevin Cleary Medical Director National Patient Safety Agency.
Advertisements

John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
Development of a Road Map to Controlled Substance Diversion Prevention Rene Cronquist, RN, J.D. Director of Practice and Policy Minnesota Board of Nursing.
Chronic Pain Initiative CCNC and Project Lazarus: Chronic Pain and Community Initiative.
Slide 1 Best Practices Working Group Chapter 244 Acts of 2012 Joint Policy Working Group Bureau of Health Care Safety and Quality Director Madeleine Biondolillo,
Naloxone (Narcan) A true opioid overdose antidote.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 1.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
Opioid Use: What are the technological, clinical, ethical, and regulatory issues? Michael Von Korff Group Health Research Institute.
What are we doing in Southern Oregon? Concerns about opioid prescribing practices.
Opioid Use in Work-related Injuries Pacific Northwest Chapter - Association of Occupational Health Professionals (AOHP) January 4, 2011 Jaymie Mai, PharmD.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Origin and Process of Utah Guidelines Anna Fondario, MPH Utah Department of Health Violence and Injury Prevention Program.
Ohio’s Opiate Epidemic
The Heroin Epidemic in rural Maryland Rural Health Learning Collaboration Sept. 28, 2015 James A. Cockey, MD, FACP Deputy Health Officer.
FDA Anesthetic & Life Support Drugs Advisory Committee Sept. 10, 2003 Art Van Zee,MD St. Charles Clinic St. Charles, Va.
Implementing a Urine Drug Screening Protocol to Teach Appropriate Opioid Prescribing in a Residency Practice STFM Annual Conference May 2, 2016 Nata Young,
Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.
One Care of SWVA A Consortium of Substance Abuse Coalitions Sarah T. Melton, PharmD,BCACP,BCPP, FASCP Chair, One Care
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for.
Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.
CDC Guideline for Prescribing Opioids for Chronic Pain- United States-2016 Gisele J. Girault, M.D. First Choice Healthcare Columbia, SC.
Oregon Prescription Drug Monitoring Program
Current Concepts in Pain Management
OPIOID EPIDEMIC.
*Risk Evaluation and Mitigation Strategy
Cover slide.
Larry Halverson, MD Gabrielle Curtis, MD Cox FMR Springfield MO
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioid Addiction in Tennessee
THE OPIOID CRISIS Mississippi Board of Nursing
Nebraska Prescription Drug Overdose Prevention Program Efforts
Medication-Assisted Therapy at Coleman Profession Services
Drug Diversion and Substance Use Disorder Management: Optimizing Collaboration Across the Continuum Michael O’Neil, Pharm.D. Professor and Chair, Department.
Caldwell County Narcotic Initiative
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Comparing abuse of extended-release versus immediate-release opioid analgesics adjusted for number of prescriptions and morphine-equivalent dose Stephen.
Barbara Sears, Director Ohio Department of Medicaid November 8, 2017
Understanding the Opioid Epidemic
Opioids in chronic pain
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Understanding the Opioid Crisis and what Kiwanis can do
ROOM project Addressing the Opioid Epidemic in the U.P.
Opioid Prescribing & Monitoring
Prescribing Opioids in Vermont
Complete a legally valid prescription.
Key Performance Indicators
MDHHS Response to the Opioid Crisis
Managing the Opioid Epidemic in Louisiana Together We Can
Barbara Allison-Bryan, MD
Pain Management Clinical Support Service and the MHS Stepped Care Model Sharon L. Rosser, DSc PA-C LTC, SP, USA Chair, Pain Management Clinical Support.
Opioids in Butte County
Review why we’re doing this work Display survey results
Opioid-related harms and responses
Prescription Drug Monitoring Program
One Step at a Time MaineHealth’s Efforts to Respond to the Opioid Crisis Caring for Me December 12, 2018.
Pain Management and Substance Use Disorders: JCPP Strategic Session
Jim Langford – Georgia Prevention Project November 5, 2018
One Step at a Time MaineHealth’s Efforts to Respond to the Opioid Crisis Caring for Me December 12, 2018.
NJ Cares Initiatives Impact on Municipalities
2019 Medicare Part D Rule Opioid-related Provisions
Impact of Policy and Regulatory Responses to the Opioid Epidemic on the Care of People with Serious Illness Hemi Tewarson, Director, Health Division National.
Prescription Drug Monitoring Program
Dr. Mark Levine, Commissioner of Health
Strategic Initiatives to Address Opioid Overdose & Addiction
Tapering and Discontinuing Chronic Opioid Therapy
PMP Advisory Committee
Presentation transcript:

Caring for ME: Leading a Positive Response to Maine’s Opioid Epidemic June 2016

Maine’s Opioid Crisis: A Rising Death Toll! 272! 2014: Maine’s overdose death rate exceeds natl avg! 2015: Maine deaths increased by 31%! *ME State Epidemiological Outcomes Workgroup (SEOW) Oct 2015 2

272 Lives Lost 272 Mainers lost to opioid/heroin deaths in 2015 ME overdose death rate increased 31% from 2014 to 2015 Maine leads nation in rate of long-acting opioid prescriptions 3

Maine’s Opioid Crisis: Affecting our Babies 1013! *Maine State Epidemiological Outcomes Workgroup (SEOW) – Oct 2015

1013 Maine Babies Impacted at Birth 1 in 11 babies in Maine born drug-affected in 2015 Maine’s infant mortality rate (7.1/1000) above national average, and climbing 5

What If… Imagine the Headlines? 272 Mainers Die of Flu… Over 1000 Maine Babies Sickened by Environmental Toxin… 272 Mainers Killed by Drunk Drivers… 6

And we are contributing! Opioid Crisis = Largest Iatrogenic Public Health Disaster in US History And we are contributing! 80% of people arrested for heroin report opioid use started with prescription meds – legally or illegally obtained! Huge levels of diversion of prescribed meds Youth particularly at risk for using diverted opioids – medicine cabinets, “pill parties” 7

Clinicians & Opioid Prescribing: A Brief History Pre-1990’s: clinicians trained to prescribe opioids rarely, high concerns for addiction potential 1990s: shift in clinical approach to pain management 1996: Purdue Pharma releases OxyContin; aggressively markets as low addiction potential 1998: VA, JCAHO promote “pain as 5th vital sign”; urge clinicians to aggressively control pain 2002: U.S. clinicians write 6.2M rx’s for OxyContin 2008: Fatalities from drug overdose in U.S. surpass MVAs 2014: Opioids prescribed at 4X rate vs. 1999 8

Opioid Prescribing in Maine In 2012, Maine had highest rate in U.S. for prescribing of long-acting opioids (Oxycontin) Maine clinicians wrote over 1.2 Million rx’s for opioids to ~336,000 people 25% of ME’s entire population! 85 opioid prescriptions for every 100 residents Maine clinicians prescribed >81 Million opioid pills On avg, ~60 opioid pills prescribed to every Mainer! 9

Opiate Abuse Affects 60% Mainers “Opiate abuse crisis touches 6 out of 10 Mainers poll results reveal”, Portland Press Herald, Eric Russell, June 28, 2016

Risks of High-Dose Opioid Prescribing Accidental fatal overdose risk increases w/ opioid dose: Risk of death 2X with doses >50 – 100 MME/day Risk of death 9X with doses >100 MME/day 1 death for every 550 patients started on opioids, within median 2.6yrs 1 death for every 32 patients on dose ≥200 MME/d - unmatched “Number Needed to Kill”! “We know of no other medication routinely used for a nonfatal condition that kills patients so frequently” New England Journ Med 374;16 nejm.org April 21, 2016

Morphine Milligram Equivalents Drug Morphine Mg Equivalent (MME) Typical daily dose MME daily dose Codeine 0.15 30mg 4X/d 18 MME Morphine 1.0 120 Hydrocodone Oxycodone 1.5 180 Oxymorphone 3.0 20mg 4X/d 240 Hydromorphone 4.0 4mg Q4hr 96 Fentanyl patch 7.2 50mcg patch 120 MME Opioid MME Calculator: www.nyc.gov/html/doh/html/mental/MME.html

Opioids for Chronic Pain: Our 21st Century Equivalent? 13

Addressing the Crisis: Building a Comprehensive Approach Education/ Prevention/ Harm Reduction Treatment Law Enforcement Maine Opioid Collaborative 14

The Role of Clinicians & Practice Teams? Education/ Prevention/ Harm Reduction Treatment Law Enforcement Maine Opioid Collaborative 15

U.S. CDC Opioid Guidelines Published April 2016 Includes 12 specific recommendations for limiting opioid prescribing Limit opioid use, establish treatment goals before starting therapy; limit acute rx to 3-7d Aim to limit doses to <50 MME/day; avoid doses ≥90 MME/day Avoid concurrent rx for benzos & opioids http://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm

LD 1646/ Chptr 488: Act To Prevent Opiate Abuse (Prescribing Limits for Opiates) Governor’s bill – passed April 2016 Requires use of PMP for opioids & benzos Prescribers: with initial rx, then every 90d Dispensers: with high-risk conditions Limits opioid prescribing duration Initial rx: 7d; chronic rx: 30d Limits opioid prescribing dose to 100 MME/d Requires use of e-prescribing by July 2017 http://legislature.maine.gov/legis/bills/bills_127th/chapters/PUBLIC488.asp 17

LD 1646/Chptr 488: Opportunity & Risks Offers opportunities for ME clinicians: Re-examine, limit opioid prescribing patterns Identify patients on high-dose opioids Presents risks if not well implemented Need for compassionate tapering of pts on high- dose opioids Need to appropriately recognize addiction & refer for appropriate treatment

The Potential of Collective Impact Our QI work extends beyond the PCMH and Health Home practices. This year marks the end of First STEPS, a four-year process led by Dr. Amy Belisle and her QC team working with over 50 practices across the state to improve child health with a focus on improving rates of immunizations, developmental screening, healthy weight, and oral health. Among other accomplishments, First STEPS contributed to a success that made headlines recently: Maine became first in the nation for toddler immunization, with a rate of 84.7%. 19

Caring for ME Proactive, positive leadership response to Maine’s opioid crisis and (likely) legislation mandating prescribing limits Partnership of MMA & QC Promote shared communication, education & support Help providers maintain compassionate approach to chronic pain management, addiction Partners welcome! www.mainequalitycounts.org/caringforme More to come…

Clinicians & Practice Teams: Spectrum of Action Prevent opioid addiction Improve chronic pain management; shift focus from eliminating pain to improving function Improve safety of opioid prescribing Screen for & recognize addiction where it exists Offer treatment for addiction Promote harm reduction (e.g. naloxone) 21 21

https://www.mainequalitycounts.org/page/2-1451/caring-for-me 22

Controlled Medications & Chronic Pain Management PLAYBOOK www.mainequalitycounts.org/ControlledMedicationPlaybook.org Step-by-step guide complete with recommendations Recommended set of measures for quality improvement efforts Guide for improving the outcomes for patients with chronic pain Collection of workflows, templates and tools collected from Maine primary care practices Developed through collaborative effort with Maine Quality Counts, PCHC, UNE, MMA, Mercy Hospital Primary Care Practices, MPCA, Husson University School of Pharmacy, The Opportunity Alliance, Healthy Maine Partnerships, members of Maine Chronic Pain Collaborative Planning Team and practices and other organizations 2014-15 There are lots of ways to receive timely and relevant news from QC – you can join our email list, subscribe to our blog, follow us on social media and subsribe to our video channel on YouTube and subscribe to our podcast on iTunes & other podcasting apps. 23

What Can Clinicians Do? Sign on to “Caring for ME” campaign! Spread the word with clinicians & practice teams! Risks of opioid prescribing LD 1646/Chptr 488 prescribing limits All specialties: Assess for addiction potential before prescribing Check Maine PMP Offer alternatives: APAP/NSAIDs, alternative modalities Exercise particular caution when considering opioids for children, teens Primary care: offer compassionate tapering & MAT 24 24

Our Call to Action 25 David McCarthy - 29 yo Coleen Singer – 32 yo David Zysk – 33 yo 25 25

Contact Info / Questions Lisa Letourneau MD, MPH, Executive Director LLetourneau@mainequalitycounts.org Maine Chronic Pain Collaborative: www.mainequalitycounts.org/page/2-1007/chronic-pain-collaborative Amy Belisle, MD, Program Director ABelisle@mainequalitycounts.org Chris Beaudette, MS, Chronic Pain Project Manager CBeaudette@mainequalitycounts.org Karyn Wheeler, Chronic Pain Project Manager Kwheeler@mainequalitycounts.org 26